Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 16/20 | 0.77 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.40 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.40 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.40 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21496525 | 1.00 | IDO1 (0.77) | IDO1S1PR3KCNQ3KCNQ2KCNE1 | |
| SCHEMBL30055476 | 1.00 | IDO1 (0.77) | IDO1S1PR3KCNQ3KCNQ2KCNE1 | |
| SCHEMBL21496542 | 0.90 | IDO1 (0.70) | IDO1S1PR3 | |
| SCHEMBL21496543 | 0.90 | IDO1 (0.70) | IDO1S1PR3 | |
| SCHEMBL24118294 | 0.88 | IDO1 (0.86) | IDO1 | |
| SCHEMBL30056153 | 0.88 | IDO1 (0.86) | IDO1 | |
| SCHEMBL24118299 | 0.87 | IDO1 (1.00) | IDO1KCNQ3KCNQ2KCNE1KCNQ1 | |
| SCHEMBL21496274 | 0.87 | IDO1 (1.00) | IDO1KCNQ3KCNQ2KCNE1KCNQ1 | |
| SCHEMBL21496273 | 0.87 | IDO1 (1.00) | IDO1KCNQ3KCNQ2KCNE1KCNQ1 | |
| SCHEMBL30055286 | 0.87 | IDO1 (1.00) | IDO1KCNQ3KCNQ2KCNE1KCNQ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781142-A1 | NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | Merck Sharp&Dohme Corp. (US) | 2021-02-24 | — | — | EP | claimed |
| WO-2019204180-A1 | NOVEL [1.1.1] BICYCLO COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2019-10-24 | — | — | WO | claimed |